Beacon Cancer Care

Beacon Cancer Care

MISSION STATEMENT/PHILOPSOPHY: To meet patients wherever they are on their cancer journey and walk with them on that journey; to provide compassionate, personalized cancer care for an unparalleled patient experience. LOCATIONS: Coeur D’ Alene, ID PRACTICE...

Nubeqa Update – New Safety Data Poster Presented at ASCO

Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide Darolutamide is a structurally distinct androgen-receptor inhibitor that is approved for the treatment of nonmetastatic, castration-resistant prostate cancer. In the planned primary...

Approval of GAVRETO™ (pralsetinib)

CAMBRIDGE, Mass., September 4, 2020 – Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that the U.S. Food and Drug Administration (FDA) has...